News About: Pharm. Industry
Lee Seung-hoon named Novartis medical advisorNovartis Korea said it has appointed Dr. Lee Seung-hoon as a new medical advisor.
Lee, 32, will head two units of Transplantation & Immunology (IDTI) and Ophthalmics Business...
|
GWP movement is now expanding
The notion of becoming a great place to work has become recognized by a number of pharmaceutical firms as a prime means to both improve their workplace environments and, in doing so, their image and financial performa...
HANS BIOMED, Ildong sign silicone gel sheet
HANS BIOMED has signed a strategic agreement with Ildong Pharm so that Ildong will exclusively distribute HANS BIOMED’s own self-adhesive get sheet, Scar Clinic, for treating both existing and new scars in Korea.
F...
Statins recommended for hyperlipidemic patients
“If pharmacologic therapy is insufficient after therapeutic life changes in patients with hyperlipidemia, lipid-lowering agents (e.g., statins) should be chosen based on the specific lipoprotein disorder presentation ...
Patients get access to Atacand 32mgAstraZeneca Korea said it has marketed Atacand (candesartan cilexetil) 32mg in addition to 4, 8, and 16 mg for an easier administration in patients with hypertension.
Atacand...
|
Kukje aggressively to enter obese therapeutic markets.
Kukje (President: Na Jong-hoon) took a launching ceremony for a new anti-obesity drug at Human Development Board of Korea Oil Pipeline Corporation on Sept. 12, indicating that 4 new drugs for the treatment of obesity ...
Hanmi Pharm buys 1% stake in Dong-A Pharm
Rumors are spreading that Hanmi Pharm did buy up a 1-percent stake in Dong-A Pharm at the end of last year to support Dong-A's chairman Kang Shin-ho.
Hanmi denied such allegations flatly, saying its buying is close...
Drug industry only to survive by core and competence strategy.
Given the situation where most of local pharmaceutical industries have encountered with many external environmental challenges such as the FTA with the United States, the adoption of new drug pricing control system ca...
Korea has strong R&D powerhouse, Pfizer management says
"I am really surprised at Korean researchers and facilities for their top-notch expertise in basic and clinical testing," said Declan Doogan, vice president of Pfzier Inc. prior to his departure immediately after his ...
Mark Jaggers becomes Sandoz Korea President
Sandoz Korea announced the appointment of Mark Jaggers, a former manager of Sandoz Australia, as president of Sandoz Korea.
Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company deve...
